PrEPVacc, an African-led, European-supported HIV prevention study running in East and Southern Africa, will help inform future vaccine implementation and uptake strategies across the region, says project lead Professor Sheena McCormack (MRC Clinical Trials Unit at UCL).
Read: Guardian
Close
